Cg Oncology, Inc. Common Stock

CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates

CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference

Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics

CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC

CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference